D Bichescu-Burian1, C Cerisier2, A Czekaj2, J Grempler2, S Hund2, S Jaeger2, P Schmid2, G Weithmann2, T Steinert2. 1. Klinik für Psychiatrie und Psychotherapie I, Universität Ulm/Zentrum für Psychiatrie Südwürttemberg, Weingartshofer Str. 2, 88214, Ravensburg, Deutschland. DanaMaria.BichescuBurian@zfp-zentrum.de. 2. Klinik für Psychiatrie und Psychotherapie I, Universität Ulm/Zentrum für Psychiatrie Südwürttemberg, Weingartshofer Str. 2, 88214, Ravensburg, Deutschland.
Abstract
BACKGROUND: In Germany, in-patient treatment of patients with depressive, neurotic, anxiety, and somatoform disorders (ICD-10 F3, F4) is carried out in different settings in psychiatry and psychosomatics. Which patient characteristics determine referral to one or the other specialty is a crucial question in mental health policy and is a matter of ongoing controversy. However, comparative data on patient populations are widely lacking. METHODS: In the study of Treatment Pathways of Patients with Anxiety and Depression (PfAD study), a total of 320 patients with ICD-10 F3/F4 clinical diagnoses were consecutively recruited from four treatment settings (psychiatric depression ward, psychiatric crisis intervention ward, psychiatric day hospitals, or psychosomatic hospital units; 80 participants per setting) and investigated. RESULTS: In all treatment settings, patients with considerable severity of illness and chronicity were treated. Female gender, higher education, and higher income predicted referral to psychosomatic units; male gender, transfer from another hospital or emergency hospitalization, co-morbidity with a personality disorder, higher general psychiatric co-morbidity, and danger to self at admission predicted referral to psychiatric unit. Patients in psychosomatic units had neither more psychosomatic disorders nor more somatic problems. DISCUSSION: There is considerable overlap between the clientele of psychiatric and psychosomatic units. Referral and allocation appears to be determined by aspects of severity and social status.
BACKGROUND: In Germany, in-patient treatment of patients with depressive, neurotic, anxiety, and somatoform disorders (ICD-10 F3, F4) is carried out in different settings in psychiatry and psychosomatics. Which patient characteristics determine referral to one or the other specialty is a crucial question in mental health policy and is a matter of ongoing controversy. However, comparative data on patient populations are widely lacking. METHODS: In the study of Treatment Pathways of Patients with Anxiety and Depression (PfAD study), a total of 320 patients with ICD-10 F3/F4 clinical diagnoses were consecutively recruited from four treatment settings (psychiatric depression ward, psychiatric crisis intervention ward, psychiatric day hospitals, or psychosomatic hospital units; 80 participants per setting) and investigated. RESULTS: In all treatment settings, patients with considerable severity of illness and chronicity were treated. Female gender, higher education, and higher income predicted referral to psychosomatic units; male gender, transfer from another hospital or emergency hospitalization, co-morbidity with a personality disorder, higher general psychiatric co-morbidity, and danger to self at admission predicted referral to psychiatric unit. Patients in psychosomatic units had neither more psychosomatic disorders nor more somatic problems. DISCUSSION: There is considerable overlap between the clientele of psychiatric and psychosomatic units. Referral and allocation appears to be determined by aspects of severity and social status.
Authors: Thomas Probst; Friedrich von Heymann; Michael Zaudig; Jürgen Konermann; Claas Lahmann; Thomas Loew; Karin Tritt Journal: Z Psychosom Med Psychother Date: 2009 Impact factor: 0.791
Authors: M Marshall; R Crowther; A Almaraz-Serrano; F Creed; W Sledge; H Kluiter; C Roberts; E Hill; D Wiersma; G R Bond; P Huxley; P Tyrer Journal: Health Technol Assess Date: 2001 Impact factor: 4.014
Authors: Elisabeth Schramm; Dietrich van Calker; Petra Dykierek; Klaus Lieb; Sabine Kech; Ingo Zobel; Rainer Leonhart; Mathias Berger Journal: Am J Psychiatry Date: 2007-05 Impact factor: 18.112
Authors: D V Sheehan; Y Lecrubier; K H Sheehan; P Amorim; J Janavs; E Weiller; T Hergueta; R Baker; G C Dunbar Journal: J Clin Psychiatry Date: 1998 Impact factor: 4.384